The effect of nesfatin-1 levels on paroxysmal supraventricular tachycardia

Journal of Investigative Medicine

Volumn 61, Issue 5, 2013, Pages 852-855

  Celik, Ahmet ^a   Gurger, Mehtap ^b   Can, Çagdas ^b   Balin, Mehmet ^a   Gul, Evrim ^b   Kobat, Mehmet Ali ^a   Gumusay, Umut ^b   Sahan, Mustafa ^b   Bursali, Kazim Burak ^b   Celiker, Ilyas ^b   Aydin, Suna ^b   Aydin, Suleyman ^c  

^a Departments of Cardiology   (Turkey)

^b School of Medicine ^*  (Turkey)

^c FIRAT UNIVERSITY   (Turkey)

Author keywords

Nesfatin 1; Neuropeptide Y; Paroxysmal supraventricular tachycardia

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; NESFATIN 1; NEUROPEPTIDE; NEUROPEPTIDE Y; OXYTOCIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEART ARRHYTHMIA; HEART RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; SENSITIVITY AND SPECIFICITY; VAGUS NERVE STIMULATION;

ADULT; CALCIUM-BINDING PROTEINS; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; NERVE TISSUE PROTEINS; ROC CURVE; TACHYCARDIA, PAROXYSMAL; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 84881485460     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e31828dedd2     Document Type: Article

References (27)

1. García-Galiano D., Navarro VM, Gaytan F, et al Expanding roles of NUCB2/nesfatin-1 in neuroendocrine regulation. J Mol Endocrinol. 2010; 45:281-290.
2. Yosten GL, Samson WK Nesfatin-1 exerts cardiovascular actions in brain: possible interaction with the central melanocortin system. Am J Physiol Regul Integr Comp Physiol. 2009; 297:330-336.
3. Price CJ, Hoyda TD, Samson W.K., et al Nesfatin-1 influences the excitability of paraventricular nucleus neurones. J Neuroendocrinol. 2008; 20:245-250.
4. Maejima Y, Sedbazar U, Suyama S., et al Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab. 2009; 10:355-365.
5. Stengel A, Goebel M, Wang L., et al Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor. Endocrinology. 2009; 150:4911-4919.
6. Foo KS, Brismar H, Broberger C. Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS. Neuroscience. 2008; 156:563-579.
7. Kohno D, Nakata M, Maejima Y., et al Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology. 2008; 149:1295-1301.
8. Ferguson AV, Samson WK The orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic function. Front Neuroendocrinol. 2003; 24:141-150.
9. Taylor MM, Keown CA, Samson WK Involvement of the central adrenomedullin peptides in the baroreflex. Regul Pept. 2003; 112:87-93.
10. Cone RD. Anatomy and regulation of the central melanocortin system. Nat Neurosci. 2005; 8:571-578.
11. Sung RJ, Castellanos A. Supraventricular tachycardia: mechanisms and treatment. Cardiovasc Clin. 1980; 11:27-34.
12. Price CJ, Samson WK, Ferguson AV Nesfatin-1 inhibits NPY neurons in the arcuate nucleus. Brain Res. 2008; 1230:99-106.
13. Jankowski M, Danalache B, Wang D., et al Oxytocin in cardiac ontogeny. Proc Natl Acad Sci U S A. 2004; 101:13074-13079.
14. Kemp AH, Quintana DS, Kuhnert R.L., et al Oxytocin increases heart rate variability in humans at rest: implications for social approach-related motivation and capacity for social engagement. PLoS One. 2012; 7:e44014.
15. Norman GJ, Cacioppo JT, Morris J.S., et al Oxytocin increases autonomic cardiac control: moderation by loneliness. Biol Psychol. 2011; 86:174-180.
16. Arlt J, Jahn H, Kellner M., et al Modulation of sympathetic activity by corticotropin-releasing hormone and atrial natriuretic peptide. Neuropeptides. 2003; 37:362-368.
17. Mimassi N, Lancien F, Mabin D., et al Induction of bradycardia in trout by centrally administered corticotropin-releasing-hormone (CRH). Brain Res. 2003; 982:211-218.
18. Oh-I S, Shimizu H., Satoh T, et al Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature. 2006; 443:709-712.
19. Gu J, Polak JM, Adrian T.E., et al Neuropeptide tyrosine (NPY)-a major cardiac neuropeptide. Lancet. 1983; 1:1008-1010.
20. Potter EK. Prolonged non-adrenergic inhibition of cardiac vagal action following sympathetic stimulation: neuromodulation by neuropeptide Y? Neurosci Lett. 1985; 54:117-121.
21. Potter E. Presynaptic inhibition of cardiac vagal postganglionic nerves by neuropeptide Y. Neurosci Lett. 1987; 83:101-106.
22. DeFerrari GM, Vanoli E, Schwartz PJ Cardiac Vagal Activity, Myocardial Ischemia and Sudden Death. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, PA: WB Saunders; 1995:422-434.
23. Head GA. Cardiac baroreflexes and hypertension. Clin Exp Pharmacol Physiol. 1994; 21:791-802.
24. Sugimoto K, Inamasu J, Kato Y., et al Association between elevated plasma norepinephrine levels and cardiac wall motion abnormality in poor-grade subarachnoid hemorrhage patients. Neurosurg Rev. 2013; 36:259-266.
25. Ilebekka A, Bjorkman JA, Nordlander M. Influence of endogenous neuropeptide Y (NPY) on the sympathetic-parasympathetic in interaction in the canine heart. J Cardiovasc Pharmacol. 2005; 46:474-480.
26. Gonzalez R, Reingold BK, Gao X, et al Nesfatin-1 exerts a direct, glucose-dependent insulinotropic action on mouse islet b- and MIN6 cells. J Endocrinol. 2011; 208:9-16.
27. Planer D, Leibowitz D, Hadid A., et al The effect of prolonged physical activity performed during extreme caloric deprivation on cardiac function. PLoS One. 2012; 7:e31266.